Current Assets 更改
Acadia Pharmaceuticals USD 675.3M 59.17M 2024-03
ALKERMES USD 1.47B 37.69M 2024-03
Alnylam Pharmaceuticals USD 2.99B 5.91M 2024-03
Biogen USD 6.76B 103.1M 2024-03
BioMarin Pharmaceutical USD 2.99B 28.92M 2024-03
Bristol-Myers Squibb USD 28.67B 1.04B 2024-03
Corcept Therapeutics USD 503.37M 44.73M 2024-03
Cytokinetics USD 638.7M 10.65M 2024-03
Eisai JPY 661B 1.73B 2023-12
Eli Lilly USD 25.19B 2.18B 2024-03
Incyte USD 4.85B 203.69M 2024-03
Intra Cellular Therapies USD 690.53M 22.73M 2024-03
J&J USD 57B 3.3B 2024-03
Moderna USD 9.6B 725M 2024-03
Neurocrine Biosciences USD 1.8B 149.1M 2024-03
Pfizer USD 42.42B 31.6B 2024-03
Prothena USD 565.87M 73.41M 2024-03
PTC Therapeutics USD 1.17B 49.89M 2024-03
Sarepta Therapeutics USD 2.46B 14.02M 2024-03
Ultragenyx Pharmaceutical USD 595.97M 3.22M 2024-03
Vertex Pharmaceuticals USD 13.29B 1.41B 2024-03



Acadia Pharmaceuticals 流动资产 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.